News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,027 Results
Type
Article (2428)
Company Profile (39)
Press Release (35560)
Section
Business (14123)
Career Advice (77)
Deals (2077)
Drug Delivery (8)
Drug Development (4101)
Employer Resources (10)
FDA (429)
Job Trends (761)
News (20139)
Policy (1051)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (143)
Allergies (4)
Alliances (3469)
ALS (4)
Alzheimer's disease (44)
Antibody-drug conjugate (ADC) (14)
Approvals (431)
Artificial intelligence (9)
Autoimmune disease (2)
Automation (1)
Bankruptcy (11)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (11)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (16)
Cancer (123)
Cardiovascular disease (4)
Career advice (64)
Career pathing (1)
CAR-T (14)
Cell therapy (41)
Cervical cancer (2)
Clinical research (3166)
Collaboration (86)
Compensation (43)
COVID-19 (180)
CRISPR (7)
C-suite (24)
Cystic fibrosis (2)
Data (93)
Denatured (3)
Depression (3)
Diabetes (9)
Diagnostics (461)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (13)
Drug pricing (7)
Duchenne muscular dystrophy (11)
Earnings (4215)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (5988)
Executive appointments (84)
FDA (469)
Featured Employer (3)
Funding (74)
Gene editing (14)
Gene therapy (15)
GLP-1 (60)
Government (149)
Healthcare (703)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (14)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (986)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (3)
Layoffs (36)
Leadership (1)
Legal (212)
Liver cancer (5)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (18)
MASH (3)
Medical device (306)
Medtech (306)
Mergers & acquisitions (1150)
Metabolic disorders (31)
Multiple sclerosis (6)
Neurodegenerative disease (7)
Neuropsychiatric disorders (3)
Neuroscience (86)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (322)
Now hiring (4)
Obesity (15)
Opinion (15)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (1)
Patents (19)
Patient recruitment (2)
Peanut (1)
People (5625)
Pharmaceutical (5)
Phase I (1371)
Phase II (1586)
Phase III (842)
Pipeline (58)
Podcasts (4)
Policy (10)
Postmarket research (30)
Preclinical (588)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (20)
Real estate (419)
Recruiting (5)
Regulatory (796)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (24)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (330)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (488)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1583)
Vaccines (28)
Venture capitalists (7)
Webinars (2)
Weight loss (11)
Women's health (1)
Worklife (1)
Date
Today (10)
Last 7 days (45)
Last 30 days (236)
Last 365 days (2556)
2025 (564)
2024 (2610)
2023 (2858)
2022 (3757)
2021 (4051)
2020 (3472)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1190)
2012 (1402)
2011 (1336)
2010 (1181)
Location
Africa (43)
Alabama (1)
Arizona (14)
Asia (1853)
Australia (299)
California (753)
Canada (126)
China (35)
Colorado (19)
Connecticut (10)
Delaware (3)
Europe (3809)
Florida (43)
Georgia (4)
Idaho (3)
Illinois (14)
India (1)
Indiana (29)
Japan (7)
Kansas (12)
Maryland (24)
Massachusetts (276)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (2)
New Hampshire (2)
New Jersey (63)
New York (43)
North Carolina (86)
Northern California (322)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (42)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (330)
Tennessee (2)
Texas (62)
Utah (2)
Virginia (5)
Washington D.C. (1)
Washington State (43)
Wisconsin (6)
38,027 Results for "genocea biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Genocea Biosciences, Solid Biosciences Slash Headcounts in Restructuring Plans
Genocea Biosciences and Solid Biosciences are undertaking a new strategic prioritization that includes reducing their headcount.
April 29, 2022
·
3 min read
·
Alex Keown
Genetown
Genocea Biosciences to Host Investor Webinar
Genocea Biosciences, Inc. today announced details for a planned investor webinar to coincide with the American Association for Cancer Research (AACR) Annual Meeting 2022, taking place April 8-13.
April 4, 2022
·
2 min read
Business
Genocea Biosciences Provides Corporate Update
Genocea Biosciences, Inc. has entered into an R&D collaboration and option agreement with Janssen Biotech, Inc., to explore the immunogenicity of neoantigens and the role and impact of Inhibigens™ in the context of vaccine therapies for cancer.
January 4, 2022
·
6 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Business
John Lunger, of Adaptimmune, Joins Genocea Biosciences’ Board of Directors
Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics plc (“Adaptimmune”), has joined its board of directors.
March 7, 2022
·
3 min read
Press Releases
Aura Biosciences to Participate in Upcoming Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - March 25, 2025
March 26, 2025
·
1 min read
Press Releases
Enveric Biosciences Participating in BIO-Europe Spring®
March 18, 2025
·
4 min read
Genetown
Genocea Announces Wind Down of Operations and Delisting From NASDAQ
Genocea Biosciences, Inc. announced that its Board of Directors voted to wind down the Company’s ongoing operations and terminate the Company’s remaining employees except those deemed necessary to complete an orderly wind down.
May 24, 2022
·
1 min read
Business
Genocea Provides Fourth Quarter 2021 Corporate Update
Genocea Biosciences, Inc., a biopharmaceutical company developing next-generation neoantigen immunotherapies, provided a business update for the fourth quarter ended December 31, 2021.
March 10, 2022
·
11 min read
1 of 3,803
Next
